Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2021-10-18 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于召开2021年第二次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a notice for convening the 2021 second extraordinary general meeting of shareholders of Tianjin Ruipu Biotechnology Co., Ltd. It includes details about the meeting time, location, agenda items (such as election of independent directors and amendment of company articles), voting procedures, registration methods, and proxy forms. There is no financial data or report content, but rather an announcement and instructions related to a shareholders' meeting. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is under 5,000 characters and it is clearly a meeting notice, not a report or voting results announcement. Therefore, the correct classification is AGM Information (AGM-R).
2021-10-18 Chinese
独立董事候选人声明
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Tianjin Ruipu Biotechnology Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. There is no financial data, no discussion of company performance, no voting results, or meeting materials. The document is a regulatory compliance statement related to board/management qualifications rather than a report or announcement of financial or corporate actions. It fits best under Board/Management Information (MANG) as it pertains to the appointment and qualifications of a board member candidate.
2021-10-18 Chinese
独立董事提名人声明
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and declarations related to the nominee's eligibility and independence. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management information, specifically about director nomination and compliance with regulatory standards for independent directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 6792 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data.
2021-10-18 Chinese
第四届监事会第二十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Tianjin Ruipu Biotechnology Co., Ltd. It details decisions made in a board meeting, including approval of a related-party transaction (acquisition of 20% equity in another company) and a proposal to amend the company's articles of association. The document includes voting results and references to further detailed announcements on the official disclosure website. The document length is short (1082 characters) and primarily serves as an official announcement of board meeting resolutions rather than a full management report or financial statement. It does not contain detailed financial data or comprehensive management discussion. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management.
2021-10-18 Chinese
关于收购北京挑战农业科技有限公司20%股权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the acquisition of a 20% equity stake in Beijing Challenge Agricultural Technology Co., Ltd. by Tianjin Ruipu Biotechnology Co., Ltd. It includes comprehensive information about the transaction, the parties involved, the pricing policy, the agreement terms, the purpose and risks of the acquisition, and independent directors' opinions. The document is a formal announcement of a capital investment transaction involving related parties, with detailed disclosures as required by regulatory bodies. It is not a financial report, earnings release, or management discussion, nor is it a proxy statement or voting result. It fits best under the category of Capital/Financing Update (CAP) as it provides an update on a significant financing activity (equity acquisition) by the company.
2021-10-18 Chinese
第四届董事会第三十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Tianjin Ruipu Biotechnology Co., Ltd. It details decisions such as acquisition approval, independent director nomination, amendments to the company charter, and scheduling of a shareholders' meeting. The text includes voting results and references to further disclosures on the regulatory website. There are no financial statements or detailed financial data presented, nor is this a transcript or presentation. The document primarily reports board meeting decisions and management-level governance matters. Therefore, it fits best under 'Board/Management Information' (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA. Hence, the classification is MANG with high confidence.
2021-10-18 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.